Immuneering

IMRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$217.928 M

$3.37 -10.51%

Close of 6 Nov 2026

As of 6 Nov 2026, Immuneering (IMRX) has a market capitalization of $217.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$56.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#237Abeona TherapeuticsABEO$224.4M
#238Korro BioKRRO$219.3M
#239ImmuneeringIMRX$217.9M
#240Vanda PharmaceuticalsVNDA$217.7M
#241Greenwich LifeSciencesGLSI$214.6M

What if Immuneering were worth as much as…

Open the what-if tool →

Gold $28.2T

$436,002.13

Per share 129,570× higher

Bitcoin $1.53T

$23,591.32

Per share 7,011× higher

Apple $5.02T

$77,448.09

Per share 23,016× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Immuneering are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.